Adrian Wong1, Michael Erdman2, Drayton A Hammond3, Tara Holt4, Jenna M Holzhausen5, Michelle Horng6, Lori Lynn Huang7, Jennifer Jarvis8, Bridgette Kram9, Shawn Kram10, Christine Lesch11, Jessica Mercer12, Megan A Rech13, Ryan Rivosecchi14, Brian Stump15, Colleen Teevan16, Sarah Day17. 1. Brigham and Women's Hospital/MCPHS University, Boston, MA awong22@partners.org. 2. University of Florida Health-Jacksonville, Jacksonville, FL. 3. University of Arkansas for Medical Sciences, Little Rock, AR. 4. IU Health Methodist, Indianapolis, IN. 5. Beaumont Hospital-Royal Oak, Royal Oak, MI. 6. Henry Ford Hospital, Detroit, MI. 7. VA Medical Center, Ann Arbor, MI. 8. St. Mary's of Michigan, Saginaw, MI. 9. Duke University Hospital, Durham, NC. 10. Medical and Cardiothoracic ICU, Duke University Medical Center, Durham, NC. 11. NeuroICU, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, NY. 12. Roper St. Francis Health Care, Charleston, SC. 13. Loyola University Medical Center, Maywood, IL. 14. UPMC Presbyterian, Pittsburgh, PA. 15. Frederick Memorial Hospital, Frederick, MD. 16. Hospital of Central Connecticut, New Britain, CT. 17. Doctors Hospital OhioHealth, Columbus, OH.
Abstract
PURPOSE: Recently published practice guidelines and research reports on pharmacotherapy in critical care patient populations are summarized. SUMMARY: The Critical Care Pharmacotherapy Literature Update (CCPLU) Group is composed of over 50 experienced critical care pharmacists who evaluate 31 peer-reviewed journals monthly to identify literature pertaining to pharmacotherapy in critical care populations. Articles are chosen for summarization in a monthly CCPLU Group publication on the basis of applicability and relevance to clinical practice and strength of study design. From January to December 2015, a total of 121 articles were summarized; of these, 3 articles presenting clinical practice guidelines and 12 articles presenting original research findings were objectively selected for inclusion in this review based on their potential to change or reinforce current evidence-based practice. The reviewed guidelines address the management of intracranial hemorrhage (ICH), adult advanced cardiac life support (ACLS) and post-cardiac arrest care, and the management of supraventricular tachycardia (SVT). The reviewed research reports address topics such as nutrition in critically ill adults, administration of β-lactams for severe sepsis, anticoagulant selection in the context of continuous renal replacement therapy, early goal-directed therapy in septic shock, magnesium use for neuroprotection in acute stroke, and progesterone use in patients with traumatic brain injury. CONCLUSION: Important recent additions to the critical care pharmacy literature include updated joint clinical practice guidelines on the management of spontaneous ICH, ACLS, and SVT.
PURPOSE: Recently published practice guidelines and research reports on pharmacotherapy in critical care patient populations are summarized. SUMMARY: The Critical Care Pharmacotherapy Literature Update (CCPLU) Group is composed of over 50 experienced critical care pharmacists who evaluate 31 peer-reviewed journals monthly to identify literature pertaining to pharmacotherapy in critical care populations. Articles are chosen for summarization in a monthly CCPLU Group publication on the basis of applicability and relevance to clinical practice and strength of study design. From January to December 2015, a total of 121 articles were summarized; of these, 3 articles presenting clinical practice guidelines and 12 articles presenting original research findings were objectively selected for inclusion in this review based on their potential to change or reinforce current evidence-based practice. The reviewed guidelines address the management of intracranial hemorrhage (ICH), adult advanced cardiac life support (ACLS) and post-cardiac arrest care, and the management of supraventricular tachycardia (SVT). The reviewed research reports address topics such as nutrition in critically ill adults, administration of β-lactams for severe sepsis, anticoagulant selection in the context of continuous renal replacement therapy, early goal-directed therapy in septic shock, magnesium use for neuroprotection in acute stroke, and progesterone use in patients with traumatic brain injury. CONCLUSION: Important recent additions to the critical care pharmacy literature include updated joint clinical practice guidelines on the management of spontaneous ICH, ACLS, and SVT.
Authors: Melanie Smith Condeni; Alyson T Basting; Patrick G Costello; Ashley DePriest; Evert A Eriksson; Heather Evans; Kristie Hertel; Andre L Holder; Alyssa N Kester; Kinsey R Kowalski; Carolyn Magee Bell; Barbara McLean; Michael Reichert; Melissa Santibañez; Patrick M Wieruszewski; Andrea Sikora Newsome Journal: J Crit Care Date: 2020-12-27 Impact factor: 3.425